53 results about "Infusion therapy" patented technology

The present invention relates to delivery containers designed to deliver fluids for infusion to patients in a predetermined sequence, and methods for their construction and use. The containers described herein integrally comprise a plurality of non-fluidly connected chambers. The containers may be configured to deliver a volume of each medication of an infusion therapy in a predetermined sequence, duration, and/or interval from these chambers; alternatively, a container may be part of a larger device that provides the necessary hardware to perform such predetermined delivery. The container provides improved infusion therapy administration by reducing opportunities for error, infection, adverse drug interactions, or other complications.

A site securement device for use in medical infusion therapy to selectively and temporarily retain a section of intravascular (IV) tube. The present device includes a unitary body with uniform or non-uniform channels for temporarily receiving and retaining a section of IV tubing in one or more channels, and may include an adhesive pad attached thereto for easy attachment to the skin of a patient.

The present invention extends to a disinfection cap for disinfecting a male luer end of an infusion therapy device. The disinfection cap can include an internal reservoir containing an antimicrobial or saline solution which is sealed with a flexible septum to prevent the solution from evaporating. The septum can include one or more slits or pierceable seams that allow a male luer end of an infusion therapy device to be inserted through the septum and into the solution. While the male luer is inserted through the septum, the solution contacts both the inner and outer surfaces of the male luer. Because the septum reduces evaporation of the solution and prevents the solution from leaking out of the cap, the solution remains in contact with the male luer for a longer duration then when typical disinfection caps are used thereby increasing the effectiveness of the disinfectant.

Decades of investigations were focused on finding “gold standard” for evaluation of plasma dilution and osmolality, blood loss evaluation and prediction of bleeding or transfusion induced changes in hematocrit and hemoglobin concentration. Addressing deficiencies of existing methods, the current invention created new combined mathematical-physiological model applicable to manually operated nomograms and software in medical monitors. The mathematical model HBS Trends is used in blood transfusion and infusion therapy nomogram—HBS Nomogram—which is based on blood hemoglobin concentration and hematocrit. It is also an easy and practical tool for recording and dynamical interpretation of plasma osmolality, blood hemoglobin concentration, hematocrit and mean corpuscular hemoglobin concentration. The HBS Nomogram is a practical system for organizing blood test results in a patient's medical records. It can be used alone or, in line with existing guidelines for infusion and transfusion therapy making them more practical, cost effective and time saving in decision making.

An infusion management system includes an infusion management server configured for providing an order to an infusion device to administer an infusion and the infusion device. The infusion device may be configured for receiving the order, associating the order with a patient, and adjusting at least one setting according to the order. A method for administering an infusion, an interface for an infusion device and a computer program product are also disclosed.

To provide infusion therapy that can effectively transluminally deliver drugs or the like to a target spot without invading areas other than a diseased area. The infusion therapy is for administering a drug, cells or the like, or inserting a treatment instrument into the target diseased area. A blood vessel area including a bifurcated blood vessel connecting to the diseased area is occluded at the distal and the proximal region thereof to form an occluded area, and the drugs or the like are pumped and supplied to the occluded area, which causes the drugs or the like to flow retrogressively and retentively in the bifurcated blood vessel connecting in the occluded area, and be infused and administered to the diseased area.

The present invention relates to delivery containers designed to deliver fluids for infusion to patients in a predetermined sequence, and methods for their construction and use. The containers described herein integrally comprise a plurality of non-fluidly connected chambers. The containers may be configured to deliver a volume of each medication of an infusion therapy in a predetermined sequence, duration, and/or interval from these chambers; alternatively, a container may be part of a larger device that provides the necessary hardware to perform such predetermined delivery. The container provides improved infusion therapy administration by reducing opportunities for error, infection, adverse drug interactions, or other complications.

An infusate cassette is described for use with an IV infusion system which controls the process of administering a drug to a patient. The cassette and other aspects of the infusion system may include disposable components, external redundant volume tracking, air removal and automated purge and prime capabilities, component removal lockout mechanisms, and/or redundant automated anti-free flow devices. An IV manifold comprising an imbedded high cracking pressure anti-free flow valve is also described for use with the infusion system. The cassette, IV manifold, and other aspects of the infusion system may be provided with quality assurance mechanisms for use with integrated IV infusion.

An embodiment of the present invention comprises an adapter configured to divide a single input tubular line into multiple tubular lines used in infusion therapies, which has a manifold at one end that comprises a single input port (e.g., female luer, male luer, barbed tubular pole, or straight tubular port) to which a fluidic source may be connected, multiple output ports (e.g., female tubing ports or barbed tubular poles) to which output infusion tubular lines may be connected, a flow disburser feature to ensure even distribution of fluidic flow within the adapter, recessed slots in the sides of the adapter to clamp the output infusion tubular lines without the need for external clamps, and identifying markings on the outside of the adapter to uniquely identify each of the output tubular lines. The adapter may also incorporate an embedded flow restrictor or filter, eliminating the need for external components and their associated connectors.

A mixing device and methods of utilizing the same. More specifically, embodiments of the present disclosure relate to a mixing device that may be used to make medications and specialized pharmaceuticals for administration via intrathecal infusion therapy, or the like. A mixing device may comprise an upper chamber, a lower chamber having four compartments for accepting an amount of medication, wherein the upper chamber and the lower chamber may be coupled and may be used to mix and make medication accessible via a Luer Lock adapter, termination, or the like, wherein the device is in compliance with USP 797 standards.

According to an aspect of the present disclosure, a pump system for individualized healthcare use includes an infusion pump, a display, an input interface, and a pump controller. The pump controller is associated with a memory in which a closed set of predefined infusion therapies and a personalized identifier associated with an individual patient are stored. The pump controller is programmed to display the personalized identifier; to operate according to a first operational state, wherein the pump controller receives an input via the input interface, selects a predefined infusion therapy according to the input received, and controls the infusion pump to provide the selected predefined infusion therapy; to operate according to a second operational state; and to receive an operational state code via the input interface, and to change from the first to the second operational state only when the operational state code is received.

The present invention relates to an infusion flow adjuster which is used in order to adjust the flow rate of an infusion solution to be administered when performing infusion therapy, and relates to an infusion flow adjuster in which an arc-shaped flow path for adjusting the distance through which the infusion solution passes and a circular flow path for inducing discharge of the infusion solution that has passed through the arc-shaped flow path are constituted in a single plane, and which is easy to produce as a product for accurately adjusting the flow rate, affords convenience of handling being provided with a handle in a suitable position, and also, in addition to allowing fine adjustment of the flow rate, limits the maximum flow rate to an appropriate value, so being convenient to use during actual infusion therapy.

An antigen-loaded nanogel is formed by loading or encapsulating one or more long peptide antigens or one or more protein antigens in a hydrophobized polysaccharide. The long peptide antigen(s) or protein antigen(s) contains (or each contain) one or more CD8+ cytotoxic T cell recognition epitopes and/or one or more CD4+ helper T cell recognition epitopes, which is/are derived from the antigen. The antigen-loaded nanogel may be administered prior to administration of antigen-specific T cells to improve the efficacy of a T cell infusion therapy against an immune checkpoint inhibitor-resistant tumor. The hydrophobized polysaccharide may be pullulan having cholesteryl groups bound thereto. An immune-enhancing agent also may be administered in or with the antigen-loaded nanogel.

The invention discloses a neurology nursing bed, which comprises a bed frame. The bed frame includes a cylindrical bed side, and sleeves are arranged on the outer sides of the left and right bed sides, and the outer wall of the sleeve is provided with a The first locking screw fixed on the side of the bed, the outer wall of the casing is also provided with a fixed plate, the fixed plate is arranged vertically to the edge of one end of the casing, one side of the casing is provided with a rotating plate, and one end of the rotating plate is provided with a left and right connection. The first slot, the end of the fixed plate is located in the first slot, the rotating plate is provided with a first through hole through the fixed plate, and the first through hole is provided with a second hole for fixing the fixed plate and the rotating plate. Locking screws; the side of the rotating plate away from the first slot is provided with a connecting plate, the end of the connecting plate is provided with a second slot connected up and down, and the end of the rotating plate away from the fixed plate is located in the second slot. The invention is convenient for transfusion for comatose or paralyzed patients, and can also avoid the influence of some involuntary reflex actions of the patients on the transfusion treatment.

A portable intravenous bag positive pressure device includes a main body and an elastic positioning unit. The main body is to encircle the arm of a patient at an appropriate position with its adjustable positioning belt to secure the main body. An intravenous bag is placed into an accommodation space formed between a positioning seat of the main body and the elastic positioning unit. The elastic positioning unit applies positive pressure to the intravenous bag to continuously output an infusion liquid for infusion therapy. The device has a simple structure and is convenient for wearing and able to secure the intravenous bag firmly on the arm of the patient. It is beneficial for the patient to carry the intravenous bag and move around during infusion therapy.

The invention discloses a high-molecular targeted drug carrier used for bladder tumor perfusion treatment, and a preparation method thereof. The targeted high-molecular drug carrier is a segmented copolymer micelle drug carrier treating an aliphatic polyester as a hydrophobic phase and polyethylene oxide having a functionalized end as a hydrophilic phase, and an antitumor drug is wrapped in the hydrophobic core of a micelle or is chemically bonded with a modifiable functional group in a hydrophilic chain segment. The end group of the hydrophilic chain segment of a copolymer is modified to obtain the high-molecular drug carrier having a targeting function and a fluorescence tracing effect. The drug carrier has a substantial targeting effect on bladder tumor cells, can obviously inhibit the growth of the bladder tumor cells, realizes the stable and continuous drug release speed, and has an important application prospect in the bladder tumor perfusion treatment.